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Background
The diagnostic performance of cardiovascular magnetic
resonance (CMR) utilizing adenosine for detection of
myocardial ischemia is well established. However, adeno-
sine requires continuous infusion, which is challenging in
the CMR environment, and has frequent side effects. The
diagnostic accuracy of stress CMR using regadenoson, a
newer vasodilator agent that is administered as a single
bolus injection and has fewer side effects, has not been
well studied. The aims of this study were: (1) to deter-
mine the diagnostic accuracy of regadenoson stress CMR
when compared to coronary angiography in patients with
suspected coronary artery disease (CAD), and (2) to
study outcomes in patients with negative stress CMR
perfusion studies to confirm that there are not a signifi-
cant number of “abnormal studies” that are undetected.
Methods
We studied 126 patients with suspected CAD referred
for regadenoson stress CMR (1.5 T scanner, Philips).
Stress perfusion images were obtained during the first
pass of Gadolinium contrast agent one minute after
regadenoson (0.4mg IV bolus) injection, and followed by
reversal with aminophylline (75-125 mg). Cine imaging
was followed by rest perfusion and late gadolinium
enhancement imaging 10-15 minutes later. Patients
were divided into 2 groups according to probability of
CAD. Group 1 included 38 patients, who underwent
coronary angiography within 6 months of CMR (Table),
and was used to achieve goal 1. Significant CAD was
defined by >70% coronary stenosis. Group 2 included 88
patients with normal regadenoson CMR (defined by
normal right and left ventricular systolic volumes and
function, absence of both visible perfusion abnormalities
and LGE) who were followed-up for 12 months for
cardiac death, myocardial infarction (MI), and revascu-
larization. This group was used to achieve goal 2.
Results
In group 1, 29/38 (76%) patients had significant CAD, and
35/38 (92%) had visible stress-induced perfusion abnorm-
alities on CMR. The diagnostic accuracy of regadenoson
CMR was 89%, sensitivity 93%, specificity 89%, positive
predictive value (PPV) 96%, and negative predictive value
(NPV) 72%. In group 2, none of the 88 patients had events
within the follow-up period.
Conclusions
This study provides one of the first assessments of diag-
nostic performance of regadenoson stress CMR in clini-
cal practice, which was similar to published data for
adenosine stress CMR. Importantly, the one-year event
rate in patients with normal stress exams was <1/88, i.e.
<1.14%. With its known advantages over adenosine,
regadenoson is an effective alternative for cardiac MRI
vasodilator stress testing in both patients with high and
low probability of CAD.
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Table 1 Patient Characteristics
Men, n 15
Women, n 23
No Prior Coronary Disease, n 18




Tobacco Use, n 13
Family History, n 7
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